Cart
sales@molnova.com
Monocaprin
CAS No. 2277-23-8
Monocaprin ( —— )
Catalog No. M28795 CAS No. 2277-23-8
Monocaprin is a 1-monoglyceride of capric acid that has antimicrobial activity against enveloped viruses, certain bacteria, and the yeast Candida albicans.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 27 | Get Quote |
|
| 500MG | 50 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMonocaprin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMonocaprin is a 1-monoglyceride of capric acid that has antimicrobial activity against enveloped viruses, certain bacteria, and the yeast Candida albicans.
-
DescriptionMonocaprin is a 1-monoglyceride of capric acid that has antimicrobial activity against enveloped viruses, certain bacteria, and the yeast Candida albicans.(In Vitro): C. albicans was the micro-organism that was most sensitive to monocaprin, but S. mutans also showed appreciable sensitivity.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifection
-
Recptorsumoylation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2277-23-8
-
Formula Weight246.3
-
Molecular FormulaC13H26O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCC(OCC(CO)O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kho C, et al. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure. Nat Commun. 2015 Jun 12;6:7229.
molnova catalog
related products
-
Econazole
Econazole is an antifungal compound of the imidazole class.
-
2-Furoic acid
2-Furoic acid an orally active selective human cathepsin K inhibitor may have the therapeutic potential for the treatment of diseases characterized by excessive bone loss including osteoporosis.Furan-2-carboxylic acid also has anti-bacterial effect.
-
Rubiadin 1-methyl et...
Rubiadin 1-methyl ether is a natural product.It inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65.
